Faron Pharmaceuticals Oy (LSE:FARN) - Share price


Stock Report

Faron Pharmaceuticals Oy FARN

Last Price
GBX337.50

Day Change
-22.50|-6.25%

As of 27/05/2020
16:35:49 BST | GBX
Minimum 15 Minutes Delay.

Last Close360.00p
Day Range330.00 - 359.00
Mkt Cap168.50Mil
52-Wk Range79.00 - 595.00
Yield %-
ISINFI4000153309
Volume108,370
P/E-
P/SInfinity
P/CF-10.42

Share Price

Total Returns 27/05/2020

 Chg (%)  
More ...
Faron Pharmaceuticals Oy-8.16 
FTSE 100 TR GBP5.45
 
Financials
201720182019
More ...
Income Statement
Turnover0.000.020.00
Operating Profit-19.77-19.65-13.10
Net Profit-21.06-20.09-13.26
Reported EPS-0.76-0.65-0.31
Balance Sheet
Current Assets13.236.839.20
Non Current Assets1.661.181.01
Total Assets14.898.0010.21
Current Liabilities8.065.756.08
Total Liabilities---
Total Equity4.740.371.61
Cash Flow
Operating Cash Flow-18.36-20.52-11.51
Net Change in Cash-1.88-5.282.99
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
12/05/2020PurchaseMr. Toni Hanninen4.332,0008,667.00
12/05/2020PurchaseMr. Toni Hanninen4.321,5006,472.00
14/11/2019PurchaseDr. Frank Murdoch Armstrong199.229,0631,805,530.00
14/11/2019PurchaseMr. Toni Hanninen14,940.946,7971,015,536.00

Company Profile

Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company developing novel treatments for medicalconditions. The company currently has a pipeline focusing on acute organ traumas,vascular damage and cancer immunotherapy.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 24/09/2020

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-316.76
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Gregory B. Brown,M.D.
Non-Executive Director, ChairmanDr. Frank Murdoch Armstrong
Non-Executive Director, Vice ChairmanMr. Matti Esa Manner
Non-Executive DirectorMr. Leopoldo Giampaolo Zambeletti
Executive Director, Chief Executive OfficerDr. Markku Tapani Jalkanen
Non-Executive DirectorMr. John Poulos
Executive Director, Chief Financial OfficerMr. Toni Hanninen
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.